CLINICAL_TRIALS
trial_result
· 2011-10-26
Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA) [Phase 3]
Summary
Phase 3 study of tocilizumab (RoActemra/Actemra) in active systemic juvenile idiopathic arthritis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Juvenile Idiopathic Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2011-10-26